Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 7 SUPPL., 2009, Pages

  Brown, Daniel B ^a   Gould, Jennifer E ^a   Gervais, Debra A ^b   Goldberg, S Nahum ^c   Murthy, Ravi ^d   Millward, Steven F ^e   Rilling, William S ^f   Geschwind, Jean Francois S ^g   Salem, Riad ^h   Vedantham, Suresh ^a   Cardella, John F ⁱ   Soulen, Michael C ^j  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Peterborough Regional Health Centre   (Canada)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h NORTHWESTERN MEMORIAL HOSPITAL   (United States)

ⁱ TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; CHEMOEMBOLIZATION; CLINICAL RESEARCH; HUMAN; LIVER CANCER; NOMENCLATURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STANDARDIZATION;

EID: 67649786401     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.04.021     Document Type: Article

References (63)

1. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16 (2005) 765-778
2. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepato-cellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
4. Brown K.T., Nevins A.B., Getrajdman G.I., et al. Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9 (1998) 822-828
5. Brown K.T., Koh B.Y., Brody L.A., et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 10 (1999) 397-403
6. Stokes K., Stuart K., and Clouse M. Hepatic arterial chemoembolization for meta-static endocrine tumors. J Vasc Interv Radiol 4 (1993) 341-345
7. Ruszniewski P., Rougier P., Roche A., et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors: a prospective phase II study in 24 patients. Cancer 71 (1993) 2624-2630
8. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 (2005) 937-945
9. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepato-cellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
10. Kee S.T., Ganguly A., Daniel B.L., et al. MR-guided transjugular intrahepatic portosystemic shunt creation with use of a hybrid radiography/MR system. J Vasc Interv Radiol 16 (2005) 227-234
11. Sato K.T., Larson A.C., Rhee T.K., et al. Real-time MRI monitoring of trans-catheter hepatic artery contrast agent delivery in rabbits. Acad Radiol 12 (2005) 1342-1350
12. Brown D.B., Cardella J.F., Sacks D., et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 17 (2006) 225-232
13. Jolesz F.A. Interventional magnetic resonance imaging, computed tomography, and ultrasound. Acad Radiol 2 suppl (1995) S124-S125
14. Sanz-Altamira P.M., Spence L.D., Huber-man M.S., et al. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40 (1997) 770-775
15. Georgiades C.S., Hong K., D'Angelo M., and Geschwind J.F. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16 (2005) 1653-1659
16. Pentecost M.J., Daniels J.R., Teitelbaum G.P., and Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis. J Vasc Interv Radiol 4 (1993) 347-351
17. Kim H.C., Chung J.W., Lee W., Jae H.J., and Park J.H. Recognizing extrahepatic collateral vessels that supply hepato-cellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 25 suppl (2005) S25-S39
18. Miyayama S., Matsui O., Taki K., et al. Extrahepatic blood supply to hepato-cellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 29 (2006) 39-48
19. Zhu Q., Cronin E.B., Currier A.A., et al. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 237 (2005) 57-66
20. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
21. Wong C.Y., Qing F., Savin M., et al. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by (18F)-fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16 (2005) 1101-1106
22. Kamel I.R., Bluemke D.A., Eng J., et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17 (2006) 505-512
23. Matsuo N., Uchida H., Nishimine K., et al. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vasc Interv Radiol 4 (1993) 543-549
24. Choi B.I., Kim H.C., Han J.K., et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182 (1992) 709-713
25. Higuchi T., Kikuchi M., and Okazaki M. Hepatocellular carcinoma after trans-catheter hepatic arterial embolization: a histopathologic study of 84 resected cases. Cancer 73 (1994) 2259-2267
26. Kennedy A.S., Nutting C., Coldwell D., Gaiser J., and Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60 (2004) 1552-1563
27. Maluccio M., Covey A.M., Gandhi R., et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 16 (2005) 955-961
28. Mondazzi L., Bottelli R., Brambilla G., et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19 (1994) 1115-1123
29. Van Beers B., Roche A., Cauquil P., Jamart J., Pariente D., and Ajavon Y. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and Gel-foam embolization in hepatocellular carcinoma. Acta Radiol 30 (1989) 415-418
30. Imaeda T., Yamawaki Y., Seki M., et al. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 16 (1993) 209-213
31. Kawai S., Tani M., Okamura J., et al. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepato-cellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Semin Oncol 24 suppl (1997) S6-38-S36-45
32. Takayasu K., Shima Y., Muramatsu Y., et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163 (1987) 345-351
33. Solomon B., Soulen M., Baum R., Haskal Z., Shlansky-Goldberg R., and Cope C. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 10 (1999) 793-798
34. Brown D.B., Fundakowski C.E., LiskerMelman M., et al. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 15 (2004) 1209-1218
35. Therasse E., Breittmayer F., Roche A., et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189 (1993) 541-547
36. Varela M., and Bruix J. Hepatocellular carcinoma in the United States: lessons from a population-based study in Medicare recipients. J Hepatol 44 (2006) 8-10
37. Murthy R., Nunez R., Szklaruk J., et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25 suppl 1 (2005) S41-S55
38. Burke D.R., Lewis C.A., Cardella J.F., et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol 14 suppl (2003) S243-S246
39. Lewis C.A., Allen T.E., Burke D.R., et al. Quality improvement guidelines for central venous access. J Vasc Interv Radiol 14 suppl (2003) S231-S235
40. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
41. Gates J., Hartnell G.G., Stuart K.E., and Clouse M.E. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 19 (1999) 399-414
42. Takayasu K., Moriyama N., Muramatsu Y., et al. Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol 144 (1985) 135-138
43. Kuroda C., Iwasaki M., Tanaka T., et al. Gallbladder infarction following hepatic transcatheter arterial embolization: angiographic study. Radiology 149 (1983) 85-89
44. Kiely J.M., Rilling W.S., Touzios J.G., et al. Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol 17 (2006) 47-53
45. Caturelli E., Siena D.A., Fusilli S., et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue- long-term prospective study. Radiology 215 (2000) 123-128
46. Song S.Y., Wook Chung J., Koo Han J., et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 12 (2001) 313-320
47. Geschwind J.F., Kaushik S., Ramsey D.E., Choti M.A., Fishman E.K., and Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13 (2002) 1163-1166
48. Leung D.A., Goin J.E., Sickles C., Raskay B.J., and Soulen M.C. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 12 (2001) 321-326
49. Hirakawa M., Iida M., Aoyagi K., Matsui T., Akagi K., and Fujishima M. Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma. Am J Gastroenterol 83 (1988) 837-840
50. Blanchard R.J., Morrow I.M., and Sutherland J.B. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 40 (1989) 206-210
51. Liu D.M., Salem R., Bui J.T., et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16 (2005) 911-935
52. Bledin A.G., Kantarjian H.M., Kim E.E., et al. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemo-therapy. AJR Am J Roentgenol 139 (1982) 711-715
53. Leung T.W., Lau W.Y., Ho S.K., et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33 (1995) 919-924
54. Kishi K., Sonomura T., Satoh M., et al. Acute toxicity of lipiodol infusion into the hepatic arteries of dogs. Invest Radiol 29 (1994) 882-889
55. Chung J.W., Park J.H., Im J.G., Han J.K., and Han M.C. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187 (1993) 689-693
56. Stangl D.K. Bridging the gap between statistical analysis and decision making in public health research. Stat Med 24 (2005) 503-511
57. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34 (1976) 585-612
58. Fisher B. Clinical trials for the evaluation of cancer therapy. Cancer 54 (1984) 2609-2617
59. Sacks D., Marinelli D.L., Martin L.G., and Spies J.B. General principles for evaluation of new interventional technologies and devices. J Vasc Interv Radiol 14 (2003) S391-S394
60. Begg C.B., and McNeil B.J. Assessment of radiologic tests: control of bias and other design considerations. Radiology 167 (1988) 565-569
61. Rothmann M., Li N., Chen G., Chi G.Y., Temple R., and Tsou H.H. Design and analysis of non-inferiority mortality trials in oncology. Stat Med 22 (2003) 239-264
62. Grunkemeier G.L., and Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis 1 (1992) 142-151
63. Guyatt G.H., Feeny D.H., and Patrick D.L. Measuring health-related quality of life. Ann Intern Med 118 (1993) 622-629